Importantly, Nrp-1 is required for Treg to limit anti-tumor immune responses and to cure established inflammatory colitis (34, 43, 44), but is dispensable for the suppression of autoimmunity and maintenance of immune homeostasis (34). Here, NRP1 is linked to neoplasm.